The role of FDG-PET in pediatric Non-Hodgkin lymphoma

被引：0
|
作者：
Nakatani, K. [1 ]
Nakamoto, Y. [1 ]
Suga, T. [1 ]
Miyake, K. K. [1 ]
Kurihara, K. [1 ]
Saga, T. [2 ]
Higashi, T. [3 ]
Togashi, K. [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[2] Natl Inst Radiol Sci, Mol Imaging Ctr, Inage, Japan
[3] Shiga Med Ctr Adults, Res Inst, Moriyama, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [41] FDG-PET/CT prediction of outcome in pediatric Hodgkin lymphoma (HL)
    Radan, Lea
    Ben-Barak, Ayelet
    Arad-Cohen, Nira
    Ben-Arush, Myriam
    Israel, Ora
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [42] Critical role of FDG-PET imaging prior to radio immune therapy in patients with Non-Hodgkin's lymphoma.
    Johnson, G
    Dadparvar, S
    Rebenstock, A
    Reich, PE
    Zhuang, HM
    Newberg, AB
    Schuster, S
    Alavi, A
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 187P - 188P
  • [43] Can FDG-PET replace biopsy for the evaluation of residual tumor in pediatric mature B-cell non-Hodgkin lymphoma?
    Rahman, Hany Abdel
    El Semary, Samah Fathy
    Ahmed, Gehad
    El Kenaai, Naglaa
    Omar, Walid
    Zaky, Iman
    Nagy, Nouran
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [44] FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease
    Paes, Fabio M.
    Kalkanis, Dimitrios G.
    Sideras, Panagiotis A.
    Serafini, Aldo N.
    [J]. RADIOGRAPHICS, 2010, 30 (01) : 269 - U302
  • [45] Combined Modality Treatment for PET-Positive Non-Hodgkin Lymphoma: Favorable Outcomes of Combined Modality Treatment for Patients With Non-Hodgkin Lymphoma and Positive Interim or Postchemotherapy FDG-PET
    Halasz, Lia M.
    Jacene, Heather A.
    Catalano, Paul J.
    Van den Abbeele, Annick D.
    LaCasce, Ann
    Mauch, Peter M.
    Ng, Andrea K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (05): : E647 - E654
  • [46] Therapeutic relevance of FDG-PET in untreated Hodgkin's disease and high-grade non-Hodgkin lymphoma.
    Dittmann, H
    Dohmen, BM
    Soekler, M
    Kanz, L
    Bares, R
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 71P - 71P
  • [47] Initial study of FDG PET for pediatric non-Hodgkin lymphoma (NHL) treatment response assessment
    Chirindel, Alin
    Cho, Steve
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [48] FDG-PET in the clinical management of Hodgkin lymphoma
    Hutchings, M
    Eigtved, AI
    Specht, L
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) : 19 - 32
  • [49] Update on FDG-PET in pediatric lymphoma
    Kurch, Lars
    Kluge, Regine
    [J]. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 68 (01): : 58 - 69
  • [50] Metabolic effects of chemotherapy on the brain in Non-Hodgkin Lymphoma (NHL) patients as measured on FDG-PET/CT
    Saboury, B.
    JinHyung, A. A.
    Hofheinz, F.
    Alavi, A.
    Torigian, D. A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S427 - S427
12345